期刊
JOURNAL OF HEPATOLOGY
卷 65, 期 4, 页码 798-808出版社
ELSEVIER
DOI: 10.1016/j.jhep.2016.05.007
关键词
HCC; EMT; MET; Epithelial plasticity; Tumor heterogeneity; Cell invasion; Therapy; Patient survival
资金
- People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant [PITN-GA-2012-316549 (IT LIVER)]
- Austrian Science Fund, FWF [P25356]
- Austrian Science Fund (FWF) [P 25356] Funding Source: researchfish
- Austrian Science Fund (FWF) [P25356] Funding Source: Austrian Science Fund (FWF)
The epithelial to mesenchymal transition (EMT) is a multistep biological process whereby epithelial cells change in plasticity by transient de-differentiation into a mesenchymal phenotype. EMT and its reversal, mesenchymal to epithelial transition (MET), essentially occur during embryogenetic morphogenesis and have been increasingly described in fibrosis and cancer during the last decade. In carcinoma progression, EMT plays a crucial role in early steps of metastasis when cells lose cell-cell contacts due to ablation of E-cadherin and acquire increased motility to spread into surrounding or distant tissues. Epithelial plasticity has become a hot issue in hepatocellular carcinoma (HCC), as strong inducers of EMT such as transforming growth factor-beta are able to orchestrate both fibrogenesis and carcinogenesis, showing rising cytokine levels in cirrhosis and late stage HCC. In this review, we consider the significance of EMT-MET in malignant hepatocytes as well as changes in the plasticity of hepatic stellate cells for cellular heterogeneity of HCC, and further aim at explaining the current limiting insights into EMT by snapshot analyses of HCC tissues. Recent advances in the identification of clinically relevant mechanisms that impinge on important EMT-transcription factors, as well as on miRNAs causing EMT signatures and HCC progression are highlighted. In addition, we draw particular attention to framing EMT in the context of potential clinical relevance for HCC patients. We conclude that some aspects of EMT are still elusive and further studies are required to better link the clinical management of HCC with biomarkers and targeted therapies related to EMT. (C) 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据